Transfusion

Cover image for Vol. 52 Issue 7

July 2012

Volume 52, Issue 7

Pages 1387–1599

  1. In this issue

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. BLOOD COMPONENTS
    6. IMMUNOHEMATOLOGY
    7. TRANSFUSION COMPLICATIONS
    8. HEMOSTASIS
    9. TRANSFUSION PRACTICE
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. REVIEW
    13. LETTERS TO THE EDITOR
    1. In this issue (page 1387)

      Version of Record online: 10 JUL 2012 | DOI: 10.1111/j.1537-2995.2012.03338.x

  2. EDITORIALS

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. BLOOD COMPONENTS
    6. IMMUNOHEMATOLOGY
    7. TRANSFUSION COMPLICATIONS
    8. HEMOSTASIS
    9. TRANSFUSION PRACTICE
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. REVIEW
    13. LETTERS TO THE EDITOR
  3. TRANSFUSION MEDICINE ILLUSTRATED

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. BLOOD COMPONENTS
    6. IMMUNOHEMATOLOGY
    7. TRANSFUSION COMPLICATIONS
    8. HEMOSTASIS
    9. TRANSFUSION PRACTICE
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. REVIEW
    13. LETTERS TO THE EDITOR
    1. Massive hemolysis due to thrombotic thrombocytopenic purpura in a patient with AIDS (pages 1408–1409)

      Jill Adamski and Marisa B. Marques

      Version of Record online: 10 JUL 2012 | DOI: 10.1111/j.1537-2995.2011.03504.x

  4. BLOOD COMPONENTS

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. BLOOD COMPONENTS
    6. IMMUNOHEMATOLOGY
    7. TRANSFUSION COMPLICATIONS
    8. HEMOSTASIS
    9. TRANSFUSION PRACTICE
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. REVIEW
    13. LETTERS TO THE EDITOR
    1. Diabetes augments and inhaled nitric oxide prevents the adverse hemodynamic effects of transfusing syngeneic stored blood in mice (pages 1410–1422)

      Binglan Yu, Chong Lei, David M. Baron, Andrea U. Steinbicker, Kenneth D. Bloch and Warren M. Zapol

      Version of Record online: 10 JAN 2012 | DOI: 10.1111/j.1537-2995.2011.03473.x

    2. Development of an ethidium monoazide–enhanced internally controlled universal 16S rDNA real-time polymerase chain reaction assay for detection of bacterial contamination in platelet concentrates (pages 1423–1432)

      Poorvi Patel, Jeremy A. Garson, Kate I. Tettmar, Siobhan Ancliff, Carl McDonald, Tyrone Pitt, Juliana Coelho and Richard S. Tedder

      Version of Record online: 21 DEC 2011 | DOI: 10.1111/j.1537-2995.2011.03484.x

    3. A rest period before agitation may improve some in vitro apheresis platelet parameters during storage (pages 1433–1438)

      Andrey Skripchenko, Andrew Myrup, Helen Awatefe, Dedeene Thompson-Montgomery and Stephen J. Wagner

      Version of Record online: 29 DEC 2011 | DOI: 10.1111/j.1537-2995.2011.03493.x

    4. Exploratory in vitro study of red blood cell storage containers formulated with an alternative plasticizer (pages 1439–1445)

      Larry J. Dumont, Sharry Baker, Deborah F. Dumont, Louise Herschel, Susan Waters, Kristin Calcagni, Craig Sandford, Katherine Radwanski, Kyungyoon Min, Raymond M. David and Rainer Otter

      Version of Record online: 30 DEC 2011 | DOI: 10.1111/j.1537-2995.2011.03506.x

  5. IMMUNOHEMATOLOGY

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. BLOOD COMPONENTS
    6. IMMUNOHEMATOLOGY
    7. TRANSFUSION COMPLICATIONS
    8. HEMOSTASIS
    9. TRANSFUSION PRACTICE
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. REVIEW
    13. LETTERS TO THE EDITOR
    1. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model (pages 1446–1457)

      Heidi Tiller, Mette Kjaer Killie, Pingguo Chen, Mariana Eksteen, Anne Husebekk, Bjorn Skogen, Jens Kjeldsen-Kragh and Heyu Ni

      Version of Record online: 17 JAN 2012 | DOI: 10.1111/j.1537-2995.2011.03480.x

    2. Detection of HNA-3a and -3b antibodies using transfected cell lines and recombinant proteins (pages 1458–1467)

      Marcin J. Woźniak, Claire Bowring, Geoff Lucas and Kay Ridgwell

      Version of Record online: 29 DEC 2011 | DOI: 10.1111/j.1537-2995.2011.03490.x

    3. The first two cases of neonatal alloimmune thrombocytopenia associated with the low-frequency platelet antigen HPA-21bw (Nos) in Japan (pages 1468–1475)

      Yangsook Koh, Hiroyuki Ishii, Etsuko Amakishi, Tomoya Hayashi, Nobuki Matsuyama, Yasuo Fukumori, Fumiya Hirayama, Junji Shimizu, Shohei Nakauchi and Keisei Kawa

      Version of Record online: 29 DEC 2011 | DOI: 10.1111/j.1537-2995.2011.03491.x

    4. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia (pages 1476–1481)

      Zhaodong Xu, Lisa Duffett, Melanie Tokessy, Jacqueline Cote, Mindy Goldman and Elianna Saidenberg

      Version of Record online: 10 JAN 2012 | DOI: 10.1111/j.1537-2995.2011.03477.x

  6. TRANSFUSION COMPLICATIONS

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. BLOOD COMPONENTS
    6. IMMUNOHEMATOLOGY
    7. TRANSFUSION COMPLICATIONS
    8. HEMOSTASIS
    9. TRANSFUSION PRACTICE
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. REVIEW
    13. LETTERS TO THE EDITOR
    1. Inactivation and neutralization of parvovirus B19 Genotype 3 (pages 1490–1497)

      Johannes Blümel, Lori A. Rinckel, Douglas C. Lee, Nathan J. Roth and Sally A. Baylis

      Version of Record online: 17 FEB 2012 | DOI: 10.1111/j.1537-2995.2012.03573.x

    2. Multicenter evaluation of a commercial multiplex polymerase chain reaction test for screening plasma donations for parvovirus B19 DNA and hepatitis A virus RNA (pages 1498–1508)

      Marco H.G.M. Koppelman, H. Theo M. Cuijpers, Susanna Wessberg, Anne Valkeajärvi, Lutz Pichl, Volkmar Schottstedt and John Saldanha

      Version of Record online: 15 MAY 2012 | DOI: 10.1111/j.1537-2995.2012.03705.x

    3. Lookback investigations of Babesia microti–seropositive blood donors: seven-year experience in a Babesia-endemic area (pages 1509–1516)

      Stephanie T. Johnson, Ritchard G. Cable and David A. Leiby

      Version of Record online: 12 SEP 2011 | DOI: 10.1111/j.1537-2995.2011.03345.x

    4. The third described case of transfusion-transmitted Babesia duncani (pages 1517–1522)

      Evan M. Bloch, Barbara L. Herwaldt, David A. Leiby, Annette Shaieb, Ross M. Herron, Michael Chervenak, William Reed, Robert Hunter, Rosilyn Ryals, Ward Hagar, Maniphet V. Xayavong, Susan B. Slemenda, Norman J. Pieniazek, Patricia P. Wilkins and Anne M. Kjemtrup

      Version of Record online: 13 DEC 2011 | DOI: 10.1111/j.1537-2995.2011.03467.x

    5. Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program (pages 1523–1529)

      Carolyn Young, Anjulika Chawla, Victor Berardi, James Padbury, Gail Skowron, Peter J. Krause and the Babesia Testing Investigational Containment Study Group

      Version of Record online: 27 MAR 2012 | DOI: 10.1111/j.1537-2995.2012.03612.x

  7. HEMOSTASIS

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. BLOOD COMPONENTS
    6. IMMUNOHEMATOLOGY
    7. TRANSFUSION COMPLICATIONS
    8. HEMOSTASIS
    9. TRANSFUSION PRACTICE
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. REVIEW
    13. LETTERS TO THE EDITOR
    1. Seasonal association of thrombotic thrombocytopenic purpura (pages 1530–1534)

      Yara A. Park, Jessica L. Poisson, Matthew T. McBee and Araba Afenyi-Annan

      Version of Record online: 13 JAN 2012 | DOI: 10.1111/j.1537-2995.2011.03481.x

  8. TRANSFUSION PRACTICE

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. BLOOD COMPONENTS
    6. IMMUNOHEMATOLOGY
    7. TRANSFUSION COMPLICATIONS
    8. HEMOSTASIS
    9. TRANSFUSION PRACTICE
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. REVIEW
    13. LETTERS TO THE EDITOR
    1. Factor VIII/von Willebrand factor concentrate therapy for ventricular assist device–associated acquired von Willebrand disease (pages 1535–1541)

      Melissa Cushing, Kathy Kawaguchi, Kenneth D. Friedman and Tomer Mark

      Version of Record online: 9 JAN 2012 | DOI: 10.1111/j.1537-2995.2011.03500.x

    2. The microbiologic safety of umbilical cord blood transfusion for children with severe anemia in Mombasa, Kenya (pages 1542–1551)

      Oliver W. Hassall, Johnstone Thitiri, Greg Fegan, Lewa Pole, Salim Mwarumba, Douglas Denje, Kongo Wambua, Brett Lowe, Christopher M. Parry, Kishor Mandaliya, Kathryn Maitland and Imelda Bates

      Version of Record online: 21 DEC 2011 | DOI: 10.1111/j.1537-2995.2011.03487.x

  9. BLOOD DONORS AND BLOOD COLLECTION

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. BLOOD COMPONENTS
    6. IMMUNOHEMATOLOGY
    7. TRANSFUSION COMPLICATIONS
    8. HEMOSTASIS
    9. TRANSFUSION PRACTICE
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. REVIEW
    13. LETTERS TO THE EDITOR
    1. Iron replacement therapy in the routine management of blood donors (pages 1566–1575)

      Barbara J. Bryant, Yu Ying Yau, Sarah M. Arceo, Jennifer Daniel-Johnson, Julie A. Hopkins and Susan F. Leitman

      Version of Record online: 29 DEC 2011 | DOI: 10.1111/j.1537-2995.2011.03488.x

  10. DONOR INFECTIOUS DISEASE TESTING

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. BLOOD COMPONENTS
    6. IMMUNOHEMATOLOGY
    7. TRANSFUSION COMPLICATIONS
    8. HEMOSTASIS
    9. TRANSFUSION PRACTICE
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. REVIEW
    13. LETTERS TO THE EDITOR
    1. Improving the performance of culture-based bacterial screening by increasing the sample volume from 4 mL to 8 mL in aerobic culture bottles (pages 1576–1582)

      Stephanie Souza, Marjorie Bravo, Terri Poulin, Sandra Vanderpool, Hany Kamel, Peter Tomasulo and Leon L. Su

      Version of Record online: 29 DEC 2011 | DOI: 10.1111/j.1537-2995.2011.03489.x

  11. REVIEW

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. BLOOD COMPONENTS
    6. IMMUNOHEMATOLOGY
    7. TRANSFUSION COMPLICATIONS
    8. HEMOSTASIS
    9. TRANSFUSION PRACTICE
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. REVIEW
    13. LETTERS TO THE EDITOR
    1. Continuing Medical Education Program in Transfusion (page 1583)

      Anne F. Eder

      Version of Record online: 10 JUL 2012 | DOI: 10.1111/j.1537-2995.2012.03795.x

    2. Iron deficiency syndromes and iron-restricted erythropoiesis (CME) (pages 1584–1592)

      Lawrence Tim Goodnough

      Version of Record online: 29 DEC 2011 | DOI: 10.1111/j.1537-2995.2011.03495.x

  12. LETTERS TO THE EDITOR

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. BLOOD COMPONENTS
    6. IMMUNOHEMATOLOGY
    7. TRANSFUSION COMPLICATIONS
    8. HEMOSTASIS
    9. TRANSFUSION PRACTICE
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. REVIEW
    13. LETTERS TO THE EDITOR
    1. In reply (pages 1594–1595)

      Yara A. Park, Jessica L. Poisson, Matthew T. McBee and Araba Afenyi-Annan

      Version of Record online: 10 JUL 2012 | DOI: 10.1111/j.1537-2995.2012.03627.x

    2. Transfusion of older blood and risk of death: unanswered questions (pages 1595–1596)

      Daniel Ka Leung Cheuk

      Version of Record online: 10 JUL 2012 | DOI: 10.1111/j.1537-2995.2012.03577.x

    3. Posttransfusion red blood cell (RBC) survival determined using biotin-labeled RBCs has distinct advantages over labeling with 51Cr (pages 1596–1598)

      Donald M. Mock, John A. Widness, Ronald G. Strauss and Robert S. Franco

      Version of Record online: 10 JUL 2012 | DOI: 10.1111/j.1537-2995.2012.03588.x

    4. Assessing causality in the transmission of viruses by blood products (page 1598)

      Albert Farrugia and Mary Gustafson

      Version of Record online: 10 JUL 2012 | DOI: 10.1111/j.1537-2995.2012.03614.x

    5. In reply (pages 1598–1599)

      Peter Simmonds, Colin P. Sharp, Sharyne Donfield and Edward D. Gomperts

      Version of Record online: 10 JUL 2012 | DOI: 10.1111/j.1537-2995.2012.03664.x

SEARCH

SEARCH BY CITATION